Press Releases
Problems Plague Medicare’s Method for Measuring Payment Errors American Association for Homecare
The American Association for Homecare reported in this week's Mobility Matters publication that the U.S. Department of Health and Human Services (HHS) has uncovered serious flaws in the methodology used to calculate the error rate on payments for...
Press Releases
Acquisition of the Healthcare Business of Thomson Reuters by Veritas Capital Completed
The previously announced $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital was completed today. The company’s many well-known brands, established in more than 30 years of leadership in the...
Press Releases
Japan Pharma Portfolio Finds Renewed Strength through Record Growth in 2012
Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), announced the successful  2012 return of the Japanese Pharma Portfolio of events to the Tokyo Big Sight Exhibition Centre in Tokyo, Japan with a record attendance...
Press Releases
Allegro Diagnostics to Present at 2012 BIO International Convention
Allegro Diagnostics today announced its participation in the BIO Business Forum at the BIO International Convention, being held June 18-20 in Boston. Michael D. Webb, President and CEO, will present on Wednesday, June 20...
Press Releases
Laparoscopic Liver Surgery Symposium Heads to ORLive
BroadcastMed’s premiere website, ORLive, presents the latest advances in laparoscopic liver and pancreatic surgery through an online symposium event sponsored by Covidien. Targeted towards surgeons, this symposium provides content from the recent American Hepato Pancreato Biliary Association’s 2012...
Press Releases
Lando & Anastasi, LLP Expands Biotechnology/Pharmaceutical and Electrical/Computer Patent Teams
Lando and Anastasi, LLP today announced that Julie Gottselig, Dominic Yee, and Austin Kim have joined the firm. The Cambridge-based intellectual property law firm, one of the largest IP firms in New England, continues...
Press Releases
Genentech Data Showed That People With Metastatic Colorectal Cancer Lived Longer When They Continued on Avastin Plus Chemotherapy
Genentech, a member of the Roche Group, today announced results from ML18147, a Phase III study in metastatic colorectal cancer (mCRC) that evaluated Avastin® (bevacizumab) continued with second-line chemotherapy in people who received initial Avastin plus first-line chemotherapy. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read